Geovax Labs Inc (NASDAQ: GOVX)’s stock price has increased by 0.32 compared to its previous closing price of 2.01. However, the company has seen a -10.38% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2024-10-02 that ATLANTA, Ga., Oct. 02, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will participate in a panel discussion on innovative therapies for solid tumors at the 3rd Annual ROTH Healthcare Opportunities Conference taking place on October 9, 2024 in New York, NY. Senior GeoVax management will also host one-on-one meetings with registered attendees.
Is It Worth Investing in Geovax Labs Inc (NASDAQ: GOVX) Right Now?
The stock has a 36-month beta value of 3.09. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GOVX is 8.48M, and at present, short sellers hold a 2.67% of that float. On October 30, 2024, the average trading volume of GOVX was 4.59M shares.
GOVX’s Market Performance
The stock of Geovax Labs Inc (GOVX) has seen a -10.38% decrease in the past week, with a -8.34% drop in the past month, and a -4.43% fall in the past quarter. The volatility ratio for the week is 7.34%, and the volatility levels for the past 30 days are at 8.94% for GOVX. The simple moving average for the past 20 days is -3.00% for GOVX’s stock, with a -20.87% simple moving average for the past 200 days.
Analysts’ Opinion of GOVX
Many brokerage firms have already submitted their reports for GOVX stocks, with ROTH MKM repeating the rating for GOVX by listing it as a “Buy.” The predicted price for GOVX in the upcoming period, according to ROTH MKM is $20 based on the research report published on July 16, 2024 of the current year 2024.
Maxim Group, on the other hand, stated in their research note that they expect to see GOVX reach a price target of $8. The rating they have provided for GOVX stocks is “Buy” according to the report published on November 19th, 2020.
GOVX Trading at -35.43% from the 50-Day Moving Average
After a stumble in the market that brought GOVX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.96% of loss for the given period.
Volatility was left at 8.94%, however, over the last 30 days, the volatility rate increased by 7.34%, as shares sank -5.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -64.61% lower at present.
During the last 5 trading sessions, GOVX fell by -10.67%, which changed the moving average for the period of 200-days by -59.64% in comparison to the 20-day moving average, which settled at $2.08. In addition, Geovax Labs Inc saw -62.76% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GOVX starting from DODD DAVID A, who purchase 8,000 shares at the price of $1.95 back on Aug 09 ’24. After this action, DODD DAVID A now owns 26,661 shares of Geovax Labs Inc, valued at $15,600 using the latest closing price.
DODD DAVID A, the President, CEO of Geovax Labs Inc, purchase 8,209 shares at $2.27 during a trade that took place back on Feb 22 ’24, which means that DODD DAVID A is holding 18,661 shares at $18,663 based on the most recent closing price.
Stock Fundamentals for GOVX
Current profitability levels for the company are sitting at:
- -67.32 for the present operating margin
- 0.8 for the gross margin
The net margin for Geovax Labs Inc stands at -66.53. The total capital return value is set at 11.8. Equity return is now at value -362.39, with -212.40 for asset returns.
Based on Geovax Labs Inc (GOVX), the company’s capital structure generated -0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -165.26. The debt to equity ratio resting at -0.06. The interest coverage ratio of the stock is -113.5.
Currently, EBITDA for the company is -26.67 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 39.05. The receivables turnover for the company is 1.35for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.60.
Conclusion
To sum up, Geovax Labs Inc (GOVX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
